Bisphosphonates as inhibitors of acid sphingomyelinase
申请人:Humboldt Universität zu Berlin
公开号:EP2289900A1
公开(公告)日:2011-03-02
The present invention refers to bisphosphonate and phosphonate/phosphate compounds of Formulae I and II and its use as inhibitors of aSMase enzyme activity.
Potent and Selective Inhibition of Acid Sphingomyelinase by Bisphosphonates
作者:Anke G. Roth、Daniela Drescher、Yang Yang、Susanne Redmer、Stefan Uhlig、Christoph Arenz
DOI:10.1002/anie.200903288
日期:2009.9.28
mending bones: A simple geminal aminobisphosphonate (see picture) is the most potentselective inhibitor of the acidsphingomyelinase known to date. It can be synthesized in a one‐step procedure and inhibits cell death in vitro. Since the acidsphingomyelinase is a putative drug target for inflammatory lung diseases, bisphosphonates may find application in the treatment of pulmonary diseases.